The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Teratoma Formation by Human Embryonic Stem Cells Is Site Dependent and Enhanced by the Presence of Matrigel
Abstract
When implanted into immunodeficient mice, human embryonic stem cells (hESCs) give rise to teratoma, tumor-like formations containing tissues belonging to all three germ layers. The ability to form teratoma is a sine qua non characteristic of pluripotent stem cells. However, limited data are available regarding the effects of implantation site and the methods employed for implantation on the success rate of teratoma formation. In this study, the rate of teratoma formation in immunodeficient mice was site dependent: subcutaneous (25-100%), intratesticular (60%), intramuscular (12.5%), and under the kidney capsule (100%). Co-injecting the hESCs with Matrigel increased subcutaneous teratoma formation efficiency from 25-40% to 80-100%. We did not observe site-specific differences in the teratoma composition at the histological level. However, subcutaneous teratomas were quite distinct, easy to remove, and caused minimal discomfort to the mice. Also, subcutaneous teratomas displayed larger proportion of solid tissues as opposed to cyst formation that dominated the teratomas formed at the other sites. Interestingly, a chromosomally abnormal hESCs with trisomy 20 formed teratomas where the ratio of differentiated to undifferentiated tissues was significantly decreased suggesting defective pluripotency of the cells. In conclusion, subcutaneous implantation of hESCs in presence of Matrigel appears to be the most efficient, reproducible, and the easiest approach for teratoma formation by hESCs. Also, teratoma formation can be employed to study the development defects exhibited by the chromosomally abnormal hESC lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrigel: Basement membrane matrix with biological activity
Kleinman, H. K., & Martin, G. R. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.004 · Cited by 1,673
Control of adhesion-dependent cell survival by focal adhesion kinase.
Frisch, S. M., Vuori, K., Ruoslahti, E., & Chan-Hui, P. Y. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.3.793 · Cited by 1,109
Derivation of Embryonic Stem-Cell Lines from Human Blastocysts
Cowan, C. A., Klimanskaya, I., McMahon, J., Atienza, J., Witmyer, J., Zucker, J. P., Wang, S., Morton, C. C., McMahon, A. P., Powers, D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmsr040330 · Cited by 964
Immunosurgery of mouse blastocyst.
Solter, D., & Knowles, B. B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5099 · Cited by 664
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo
Baker, D. E. C., Harrison, N. J., Maltby, E., Smith, K., Moore, H. D., Shaw, P. J., Heath, P. R., Holden, H., & Andrews, P. W. (2007) · Nature Biotechnology · doi:10.1038/nbt1285 · Cited by 636
Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells
Sullivan, G. J., Hay, D. C., Park, I.-H., Fletcher, J., Hannoun, Z., Payne, C. M., Dalgetty, D., Black, J. R., Ross, J. A., Samuel, K., et al. (2010) · Hepatology · doi:10.1002/hep.23335 · Cited by 445
Spontaneous Testicular Teratomas in an Inbred Strain of Mice
Stevens, L. C., & Little, C. C. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.11.1080 · Cited by 379
Derivation, Characterization, and Differentiation of Human Embryonic Stem Cells
Heins, N., Englund, M. C. O., Sjöblom, C., Dahl, U., Tonning, A., Bergh, C., Lindahl, A., Hanson, C., & Semb, H. (2004) · STEM CELLS · doi:10.1634/stemcells.22-3-367 · Cited by 316
A defined glycosaminoglycan-binding substratum for human pluripotent stem cells
Klim, J. R., Li, L., Wrighton, P. J., Piekarczyk, M. S., & Kiessling, L. L. (2010) · Nature Methods · doi:10.1038/nmeth.1532 · Cited by 271
Stojkovic, P., Lako, M., Stewart, R., Przyborski, S., Armstrong, L., Evans, J., Murdoch, A., Strachan, T., & Stojkovic, M. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0137 · Cited by 232
Teratomas from pluripotent stem cells: A clinical hurdle
Fong, C., Gauthaman, K., & Bongso, A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22775 · Cited by 222
Human embryonic stem cell transplantation to repair the infarcted myocardium
Leor, J., Gerecht, S., Cohen, S., Miller, L., Holbova, R., Ziskind, A., Shachar, M., Feinberg, M. S., Guetta, E., & Itskovitz-Eldor, J. (2007) · Heart · doi:10.1136/hrt.2006.093161 · Cited by 206
Taking stem cells to the clinic: Major challenges
Bongso, A., Fong, C., & Gauthaman, K. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21957 · Cited by 183
Complex Extracellular Matrices Promote Tissue‐Specific Stem Cell Differentiation
Philp, D., Chen, S. S., Fitzgerald, W., Orenstein, J., Margolis, L., & Kleinman, H. K. (2005) · STEM CELLS · doi:10.1634/stemcells.2002-0109 · Cited by 173
Differentiation of Human Embryonic Stem Cells After Transplantation in Immune‐Deficient Mice
Przyborski, S. A. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0014 · Cited by 169
Contribution of human embryonic stem cells to mouse blastocysts
James, D., Noggle, S., Swigut, T., & Brivanlou, A. H. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.03.026 · Cited by 160
Teratoma Formation: A Tool for Monitoring Pluripotency in Stem Cell Research
Nelakanti, R. V., Kooreman, N. G., & Wu, J. C. (2015) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc04a08s32 · Cited by 146
Pluripotency: Toward a gold standard for human ES and iPS cells
Smith, K. P., Luong, M. X., & Stein, G. S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21681 · Cited by 124
Potential of Human Embryonic Stem Cells in Cartilage Tissue Engineering and Regenerative Medicine
Toh, W. S., Lee, E. H., & Cao, T. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9222-6 · Cited by 113
Growth of Teratomas Derived from Human Pluripotent Stem Cells Is Influenced by the Graft Site
Cooke, M. J., Stojković, M., & Przyborski, S. A. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.254 · Cited by 111
Effect ofmts1 (S100A4) expression on the progression of human breast cancer cells
Grigorian, M., Ambartsumian, N. S., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G. P., & Lukanidin, E. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960917)67:6<816::aid-ijc10>3.0.co;2-# · Cited by 108
Riess, P., Molčányi, M., Bentz, K., Maegele, M., Simanski, C., Carlitscheck, C., Schneider, A., Hescheler, J., Bouillon, B., Schäfer, U., et al. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0141 · Cited by 107
Plaia, T. W., Josephson, R., Liu, Y., Zeng, X., Ording, C., Toumadje, A., Constable, S., Sherrer, E. S., Uhl, E. W., Freed, W. J., et al. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0315 · Cited by 80
Reconstituted basement‐membrane matrix modulates fibroblast activities in vitro
Emonard, H., Grimaud, J.-A., Nusgens, B., Lapière, C. M., & Foidart, J. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041330112 · Cited by 56
Fletcher, J. M., Ferrier, P. M., Gardner, J. O., Harkness, L., Dhanjal, S., Serhal, P. F., Harper, J. C., Delhanty, J. D. A., Brownstein, D. G., Prasad, Y. R., et al. (2006) · Cloning and Stem Cells · doi:10.1089/clo.2006.8.319 · Cited by 56
Self-citationBiochemical and genetic analysis of the Oka blood group antigen
Williams, B. P., Daniels, G. L., Pym, B., Sheer, D., Povey, S., Okubo, Y., Andrews, P. W., & Goodfellow, P. N. (1988) · Immunogenetics · doi:10.1007/bf00395127 · Cited by 52
Current Technology for the Derivation of Pluripotent Stem Cell Lines from Human Embryos
Hasegawa, K., Pomeroy, J. E., & Pera, M. F. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.05.010 · Cited by 37
Li, X., Jia, Q., Di, K., et al. (2007) · Cell and Tissue Research · doi:10.1007/s00441-006-0354-6 · Cited by 31
New and renewed perspectives on embryonic stem cell pluripotency
Jackson, A. H. (2007) · Frontiers in bioscience · doi:10.2741/2315 · Cited by 17
Fong, C., Chak, L.-L., Subramanian, A., Tan, J., Biswas, A., Gauthaman, K., Choolani, M. A., Chan, W., & Bongso, A. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9092-y · Cited by 14
Stem Cell Therapy: A Primer for Interventionalists and Imagers
Nikolic, B., Faintuch, S., Goldberg, S. N., Kuo, M. D., & Cardella, J. F. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.04.075 · Cited by 14
Transplantation of Human Embryonic Stem Cells to the Chick Embryo
Goldstein, R. S. (2006) · Humana Press eBooks · doi:10.1385/1-59745-046-4:137 · Cited by 14
Cited by
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Ethical and Safety Issues of Stem Cell-Based Therapy
Volarevic, V., Markovic, B. S., Gazdic, M., Volarevic, A., Jovicic, N., Arsenijevic, N., Armstrong, L., Djonov, V., Lako, M., & Stojkovic, M. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.21666 · Cited by 876
Risk factors in the development of stem cell therapy
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-29 · Cited by 753
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
Lian, I., Kim, J., Okazawa, H., Zhao, J., Zhao, B., Yu, J., Chinnaiyan, A., Israel, M. A., Goldstein, L. S. B., Abujarour, R., et al. (2010) · Genes & Development · doi:10.1101/gad.1903310 · Cited by 745
Hentze, H., Soong, P. L., Wang, S. T., Phillips, B. W., Putti, T. C., & Dunn, N. R. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.02.002 · Cited by 501
Metadata
- Authors
- Prokhorova, T. A., Harkness, L. M., Frandsen, U., Ditzel, N., Schrøder, H. D., Burns, J. S., & Kassem, M.
- Venue
- Stem Cells and Development
- Publisher
- SAGE Publications
- Published
- 2009-01
- Volume
- 18
- Issue
- 1
- Pages
- 47-54
- ISSN
- 1525-8165 (ISSN-L)
- 1547-3287
- 1557-8534
- OpenAlex
- W2073262404
- Cited by
- 277
- References
- 32
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.